• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疏水作用和氢键作用是补体抑制剂C3抑制素(compstatin)活性增强的原因。

Hydrophobic effect and hydrogen bonds account for the improved activity of a complement inhibitor, compstatin.

作者信息

Katragadda Madan, Magotti Paola, Sfyroera Georgia, Lambris John D

机构信息

Protein Chemistry Laboratory, Department of Pathology & Laboratory Medicine, School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.

出版信息

J Med Chem. 2006 Jul 27;49(15):4616-22. doi: 10.1021/jm0603419.

DOI:10.1021/jm0603419
PMID:16854067
Abstract

Tryptophans at positions 4 and 7 of compstatin, a peptide complement inhibitor, are crucial for its interaction with C3. However, the nature of their involvement has not been studied to date. Here we investigate the molecular forces involved in the C3-compstatin interactions, mediated by aromatic residues, by incorporating in these two positions various tryptophan analogues (5-methyltryptophan, 5-fluorotryptophan, 1-methyltryptophan, and 2-naphthylalanine) and assessing the resulting peptides for activity by enzyme-linked immunosorbent assay (ELISA) and binding by isothermal titration calorimetry (ITC). Of all the compstatin analogues, peptides containing 1-methyltryptophan at position 4 exhibited the highest binding affinity (Kd = 15 nM) and activity (IC50 = 0.205 microM), followed by a peptide containing 5-fluorotryptophan at position 7. Our observations suggest that hydrophobic interactions involving residues at position 4 and the hydrogen bond initiated by the indole nitrogen are primarily responsible and crucial for the increase in activity. These findings have important implications for the design of clinically useful complement inhibitors.

摘要

一种肽补体抑制剂——补体抑制素,其4位和7位的色氨酸对于它与C3的相互作用至关重要。然而,它们所涉及的具体性质至今尚未得到研究。在此,我们通过在这两个位置引入各种色氨酸类似物(5-甲基色氨酸、5-氟色氨酸、1-甲基色氨酸和2-萘丙氨酸),并通过酶联免疫吸附测定(ELISA)评估所得肽的活性以及通过等温滴定量热法(ITC)测定其结合情况,来研究由芳香族残基介导的C3 - 补体抑制素相互作用中涉及的分子力。在所有补体抑制素类似物中,4位含有1-甲基色氨酸的肽表现出最高的结合亲和力(Kd = 15 nM)和活性(IC50 = 0.205 microM),其次是7位含有5-氟色氨酸的肽。我们的观察结果表明,涉及4位残基的疏水相互作用以及由吲哚氮引发的氢键对活性的增加起主要作用且至关重要。这些发现对于设计临床上有用的补体抑制剂具有重要意义。

相似文献

1
Hydrophobic effect and hydrogen bonds account for the improved activity of a complement inhibitor, compstatin.疏水作用和氢键作用是补体抑制剂C3抑制素(compstatin)活性增强的原因。
J Med Chem. 2006 Jul 27;49(15):4616-22. doi: 10.1021/jm0603419.
2
Thermodynamic studies on the interaction of the third complement component and its inhibitor, compstatin.关于第三补体成分与其抑制剂——补体抑制素相互作用的热力学研究
J Biol Chem. 2004 Dec 31;279(53):54987-95. doi: 10.1074/jbc.M409963200. Epub 2004 Oct 15.
3
Structure-kinetic relationship analysis of the therapeutic complement inhibitor compstatin.治疗性补体抑制剂康普司他汀的结构-动力学关系分析。
J Mol Recognit. 2009 Nov-Dec;22(6):495-505. doi: 10.1002/jmr.972.
4
A new generation of potent complement inhibitors of the Compstatin family.新一代强效补体抑制剂 Compstatin 家族。
Chem Biol Drug Des. 2011 Jun;77(6):431-40. doi: 10.1111/j.1747-0285.2011.01111.x. Epub 2011 Apr 26.
5
Studies of structure-activity relations of complement inhibitor compstatin.补体抑制剂compstatin的构效关系研究。
J Immunol. 2003 Aug 15;171(4):1881-90. doi: 10.4049/jimmunol.171.4.1881.
6
C3 activation is inhibited by analogs of compstatin but not by serine protease inhibitors or peptidyl alpha-ketoheterocycles.C3激活受到compstatin类似物的抑制,但不受丝氨酸蛋白酶抑制剂或肽基α-酮杂环的抑制。
Immunopharmacology. 2000 Jul 20;48(2):199-212. doi: 10.1016/s0162-3109(00)00205-8.
7
Computational analysis of complement inhibitor compstatin using molecular dynamics.使用分子动力学对补体抑制剂 compstatin 进行计算分析。
J Mol Model. 2020 Aug 12;26(9):231. doi: 10.1007/s00894-020-04472-8.
8
Solution structure of Compstatin, a potent complement inhibitor.强效补体抑制剂C3d模拟肽(Compstatin)的溶液结构
Protein Sci. 1998 Mar;7(3):619-27. doi: 10.1002/pro.5560070311.
9
Design and NMR characterization of active analogues of compstatin containing non-natural amino acids.含非天然氨基酸的补体抑制素活性类似物的设计与核磁共振表征
J Med Chem. 2005 Jan 13;48(1):274-86. doi: 10.1021/jm0495531.
10
Development of a new pharmacophore model that discriminates active compstatin analogs.一种用于区分活性纤连蛋白抑制素类似物的新药效团模型的开发。
Chem Biol Drug Des. 2008 Oct;72(4):249-56. doi: 10.1111/j.1747-0285.2008.00709.x.

引用本文的文献

1
Intravitreal Administration of Avacincaptad Pegol in a Nonhuman Primate Model of Dry Age-Related Macular Degeneration.在干性年龄相关性黄斑变性非人灵长类动物模型中玻璃体内注射阿伐西普聚乙二醇化产物
Pharmacol Res Perspect. 2025 Feb;13(1):e70052. doi: 10.1002/prp2.70052.
2
Complement regulation in the eye: implications for age-related macular degeneration.补体调控与年龄相关性黄斑变性。
J Clin Invest. 2024 May 1;134(9):e178296. doi: 10.1172/JCI178296.
3
A guide to complement biology, pathology and therapeutic opportunity.补体生物学、病理学与治疗机会指南
Nat Rev Immunol. 2024 Feb;24(2):118-141. doi: 10.1038/s41577-023-00926-1. Epub 2023 Sep 5.
4
Insight into mode-of-action and structural determinants of the compstatin family of clinical complement inhibitors.深入了解临床补体抑制剂 compstatin 家族的作用机制和结构决定因素。
Nat Commun. 2022 Sep 20;13(1):5519. doi: 10.1038/s41467-022-33003-7.
5
Safety and efficacy of pegcetacoplan in paroxysmal nocturnal hemoglobinuria.培戈西普单抗治疗阵发性夜间血红蛋白尿的安全性和有效性。
Ther Adv Hematol. 2022 Jul 28;13:20406207221114673. doi: 10.1177/20406207221114673. eCollection 2022.
6
Deciphering the conformational landscape of few selected aromatic noncoded amino acids (NCAAs) for applications in rational design of peptide therapeutics.解析少数精选芳香族非编码氨基酸(NCAAs)的构象景观,以应用于肽类治疗药物的合理设计。
Amino Acids. 2022 Aug;54(8):1183-1202. doi: 10.1007/s00726-022-03175-z. Epub 2022 Jun 20.
7
Compstatins: the dawn of clinical C3-targeted complement inhibition.康帕他汀:C3 靶向补体抑制的临床曙光。
Trends Pharmacol Sci. 2022 Aug;43(8):629-640. doi: 10.1016/j.tips.2022.01.004. Epub 2022 Jan 25.
8
Internalisation and Biological Activity of Nucleic Acids Delivering Cell-Penetrating Peptide Nanoparticles Is Controlled by the Biomolecular Corona.递送细胞穿透肽纳米颗粒的核酸的内化和生物活性受生物分子冠的控制。
Pharmaceuticals (Basel). 2021 Jul 12;14(7):667. doi: 10.3390/ph14070667.
9
Impact of non-proteinogenic amino acids in the discovery and development of peptide therapeutics.非蛋白氨基酸在肽类治疗药物的发现和开发中的影响。
Amino Acids. 2020 Sep;52(9):1207-1226. doi: 10.1007/s00726-020-02890-9. Epub 2020 Sep 18.
10
Computational analysis of complement inhibitor compstatin using molecular dynamics.使用分子动力学对补体抑制剂 compstatin 进行计算分析。
J Mol Model. 2020 Aug 12;26(9):231. doi: 10.1007/s00894-020-04472-8.